ArticleNature metabolism2021
Author Correction: Exercise hormone irisin is a critical regulator of cognitive function.
Abstract readPublished Erratum
In one paragraph
Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Exercise and Fat: A Primer.Sports medicine - open · 2026Review
- Role Shift of Glial Cells from Physiology to Pathology in Alzheimer's Disease: The Regulatory Impact of Exercise.Neuroscience bulletin · 2026Review
- The exercise hormone irisin has neuroprotective effects in a mouse model of multiple sclerosis.Nature metabolism · 2026Article
- Potential Role of Extracellular Vesicles in Mediating Effects of Exercise on Brain Function.Advances in neurobiology · 2025Review
- Aerobic exercise reverses aging-induced depth-dependent decline in cerebral microcirculation.eLife · 2023Article
- Exercise-induced hypothalamic neuroplasticity: Implications for energy and glucose metabolism.Molecular metabolism · 2023Review
- Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities.Frontiers in endocrinology · 2023Review
Corrections and comments
- Erratum for
Authors and funding
22 authors.
Mohammad R Islam *Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sophia Valaris *Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Michael F YoungCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Erin B HaleyCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Renhao LuoCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sabrina F BondCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sofia MazueraCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Robert R KitchenCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1443-8559
Barbara J CaldaroneHarvard NeuroDiscovery Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Luis E B BettioDivision of Medical Sciences, University of Victoria, Victoria, British Colombia, Canada.
Brian R ChristieDivision of Medical Sciences, University of Victoria, Victoria, British Colombia, Canada.ORCID http://orcid.org/0000-0002-6830-0160
Angela B SchmiderNephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Roy J SobermanNephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Antoine BesnardCenter for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0929-8873
Mark P JedrychowskiDepartment of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
Hyeonwoo KimDepartment of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
Hua TuLakePharma, San Carlos, CA, USA.
Eunhee KimMassGeneral Institute for Neurodegenerative Disease, Genetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.
Se Hoon ChoiMassGeneral Institute for Neurodegenerative Disease, Genetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.
Rudolph E TanziMassGeneral Institute for Neurodegenerative Disease, Genetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.ORCID http://orcid.org/0000-0002-7032-1454
Bruce M SpiegelmanDepartment of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7658-4802
Christiane D WrannCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. cwrann@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-6066-8799
Funding
Role of B7-1 in Podocytes in Pathogenesis of ProteinuriaR01DK062472 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SOBERMAN, ROY · 2004 to 2017
$5.3MLy6 family members in neutrophil biologyR01AR065538 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI NIGROVIC, PETER A · 2014 to 2024
$4.0MThe Role of lncRNA MEG3 in Clinically Non-functioning Pituitary AdenomasR01CA193520 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SOBERMAN, ROY · 2016 to 2020
$1.9MThe Macromolecular Organization of Leukotriene Synthesis and Renal InflammationK01DK089145 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI SCHMIDER, ANGELA BAIR · 2011 to 2015
$798kMolecular mechanisms of exercise benefits in synapse plasticity and cognitionR00NS087096 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WRANN, CHRISTIANE D. · 2017 to 2019
$745kDissecting the molecular mediators of the neuroprotective effects of exercise in Alzheimer's DiseaseR56AG064580 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI WRANN, CHRISTIANE D. · 2019 to 2019
$590kMolecular mechanisms of exercise benefits in synapse plasticity and cognitionK99NS087096 · NINDS · DANA-FARBER CANCER INST · PI WRANN, CHRISTIANE D. · 2014 to 2015
$223kU.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA193520U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1R01AR065538U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) K01DK089145U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK06247U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK062472U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS087096U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG064580
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
34621079What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.